The motor phenotype of Parkinson's disease in relation to age at onset.

BACKGROUND: Parkinson's disease (PD) is heterogeneous and age at onset may define variation in clinical phenotype. Most previous studies have used various age cut-offs and have been based on clinical case series. METHODS: We have studied the association between clinical features and age of ons...

Full description

Bibliographic Details
Main Authors: Wickremaratchi, M, Knipe, MD, Sastry, B, Morgan, E, Jones, A, Salmon, R, Weiser, R, Moran, M, Davies, D, Ebenezer, L, Raha, S, Robertson, N, Butler, C, Ben-Shlomo, Y, Morris, H
Format: Journal article
Language:English
Published: 2011
_version_ 1797087484715204608
author Wickremaratchi, M
Knipe, MD
Sastry, B
Morgan, E
Jones, A
Salmon, R
Weiser, R
Moran, M
Davies, D
Ebenezer, L
Raha, S
Robertson, N
Butler, C
Ben-Shlomo, Y
Morris, H
author_facet Wickremaratchi, M
Knipe, MD
Sastry, B
Morgan, E
Jones, A
Salmon, R
Weiser, R
Moran, M
Davies, D
Ebenezer, L
Raha, S
Robertson, N
Butler, C
Ben-Shlomo, Y
Morris, H
author_sort Wickremaratchi, M
collection OXFORD
description BACKGROUND: Parkinson's disease (PD) is heterogeneous and age at onset may define variation in clinical phenotype. Most previous studies have used various age cut-offs and have been based on clinical case series. METHODS: We have studied the association between clinical features and age of onset in 358 community-based and regional patients with PD. RESULTS: Tremor at presentation is twice as common in those with onset over 64 years as compared to those with onset under 45 (early onset PD - EOPD) and becomes more common with increasing age at onset (p values for trend ≤ 0.004). Dystonia affects 60% of those with EOPD, shows a curvilinear relationship with age at onset (cubic versus linear p=0.01) with highest risk in patients whose disease began before 48 years. In this study age at onset was a strong predictor of the development of dyskinesias, with younger age associated with a higher risk of dyskinesias. Following multivariable analysis, allowing for possibly confounding factors (disease duration, L-DOPA dosage, L-DOPA treatment duration) younger age at onset, (less than 55 years) predicted the development of L-DOPA induced dyskinesia (odds ratio <45 years 2.1, 95% CI 1.0, 4.8; odds ratio < 55 years 3.8, 95% CI 1.8, 8.0). Only 2/70 (2.9%) EOPD patients carried pathogenic parkin or PINK1 mutations and the clinical differences between early and late onset disease were not explained by the presence of mutations in these genes. DISCUSSION: This study highlights the clinical differences between early and late onset PD, which have important implications for diagnosis and management.
first_indexed 2024-03-07T02:36:18Z
format Journal article
id oxford-uuid:a8e86283-edb1-43d2-bbf1-9a14134a97b0
institution University of Oxford
language English
last_indexed 2024-03-07T02:36:18Z
publishDate 2011
record_format dspace
spelling oxford-uuid:a8e86283-edb1-43d2-bbf1-9a14134a97b02022-03-27T03:04:50ZThe motor phenotype of Parkinson's disease in relation to age at onset.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a8e86283-edb1-43d2-bbf1-9a14134a97b0EnglishSymplectic Elements at Oxford2011Wickremaratchi, MKnipe, MDSastry, BMorgan, EJones, ASalmon, RWeiser, RMoran, MDavies, DEbenezer, LRaha, SRobertson, NButler, CBen-Shlomo, YMorris, H BACKGROUND: Parkinson's disease (PD) is heterogeneous and age at onset may define variation in clinical phenotype. Most previous studies have used various age cut-offs and have been based on clinical case series. METHODS: We have studied the association between clinical features and age of onset in 358 community-based and regional patients with PD. RESULTS: Tremor at presentation is twice as common in those with onset over 64 years as compared to those with onset under 45 (early onset PD - EOPD) and becomes more common with increasing age at onset (p values for trend ≤ 0.004). Dystonia affects 60% of those with EOPD, shows a curvilinear relationship with age at onset (cubic versus linear p=0.01) with highest risk in patients whose disease began before 48 years. In this study age at onset was a strong predictor of the development of dyskinesias, with younger age associated with a higher risk of dyskinesias. Following multivariable analysis, allowing for possibly confounding factors (disease duration, L-DOPA dosage, L-DOPA treatment duration) younger age at onset, (less than 55 years) predicted the development of L-DOPA induced dyskinesia (odds ratio <45 years 2.1, 95% CI 1.0, 4.8; odds ratio < 55 years 3.8, 95% CI 1.8, 8.0). Only 2/70 (2.9%) EOPD patients carried pathogenic parkin or PINK1 mutations and the clinical differences between early and late onset disease were not explained by the presence of mutations in these genes. DISCUSSION: This study highlights the clinical differences between early and late onset PD, which have important implications for diagnosis and management.
spellingShingle Wickremaratchi, M
Knipe, MD
Sastry, B
Morgan, E
Jones, A
Salmon, R
Weiser, R
Moran, M
Davies, D
Ebenezer, L
Raha, S
Robertson, N
Butler, C
Ben-Shlomo, Y
Morris, H
The motor phenotype of Parkinson's disease in relation to age at onset.
title The motor phenotype of Parkinson's disease in relation to age at onset.
title_full The motor phenotype of Parkinson's disease in relation to age at onset.
title_fullStr The motor phenotype of Parkinson's disease in relation to age at onset.
title_full_unstemmed The motor phenotype of Parkinson's disease in relation to age at onset.
title_short The motor phenotype of Parkinson's disease in relation to age at onset.
title_sort motor phenotype of parkinson s disease in relation to age at onset
work_keys_str_mv AT wickremaratchim themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT knipemd themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT sastryb themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT morgane themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT jonesa themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT salmonr themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT weiserr themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT moranm themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT daviesd themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT ebenezerl themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT rahas themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT robertsonn themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT butlerc themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT benshlomoy themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT morrish themotorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT wickremaratchim motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT knipemd motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT sastryb motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT morgane motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT jonesa motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT salmonr motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT weiserr motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT moranm motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT daviesd motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT ebenezerl motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT rahas motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT robertsonn motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT butlerc motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT benshlomoy motorphenotypeofparkinsonsdiseaseinrelationtoageatonset
AT morrish motorphenotypeofparkinsonsdiseaseinrelationtoageatonset